Search Results - "Lemarié, Jean"
-
1
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension
Published in The American heart journal (01-02-2014)“…Background Continuous infusion of epoprostenol is the treatment of choice in patients with pulmonary arterial hypertension in functional classes III to IV…”
Get full text
Journal Article -
2
The efficacy of a glial inhibitor, minocycline, for preventing persistent pain after lumbar discectomy: A randomized, double-blind, controlled study
Published in Pain (Amsterdam) (01-08-2013)“…Perioperative minocycline administration for 8days after lumbar discectomy does not improve persistent pain. Minocycline strongly inhibits microglial…”
Get full text
Journal Article -
3
A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease
Published in Fundamental & clinical pharmacology (01-08-2012)“…To explore for the first time the tolerability and efficacy of naftazone in patients with Parkinson’s disease (PD). Proof‐of‐concept, randomized, double‐blind,…”
Get full text
Journal Article -
4
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Published in The European respiratory journal (01-08-2015)“…The safety and efficacy of adding bosentan to sildenafil in pulmonary arterial hypertension (PAH) patients was investigated.In this prospective, double-blind,…”
Get full text
Journal Article -
5
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-05-2024)“…Objective The evidence‐based DETECT pulmonary arterial hypertension (PAH) algorithm is frequently used in patients with systemic sclerosis (SSc) to help…”
Get full text
Journal Article -
6
Validation of two predictive models for survival in pulmonary arterial hypertension
Published in The European respiratory journal (01-07-2015)“…The French Pulmonary Hypertension Network (FPHN) registry and the Registry to Evaluate Early And Long-term Pulmonary Arterial Hypertension Disease Management…”
Get full text
Journal Article -
7
Heart failure care in low- and middle-income countries: a systematic review and meta-analysis
Published in PLoS medicine (01-08-2014)“…Heart failure places a significant burden on patients and health systems in high-income countries. However, information about its burden in low- and…”
Get full text
Journal Article -
8
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients
Published in International journal of cardiology (15-03-2014)“…Abstract Background The double-blind phase of the EARLY study of bosentan remains the only randomized controlled trial of a PAH-targeted therapy in World…”
Get full text
Journal Article -
9
Long-Term Outcomes in Children With Pulmonary Arterial Hypertension Treated With Bosentan in Real-World Clinical Settings
Published in The American journal of cardiology (01-11-2010)“…Treatment algorithms in pediatric pulmonary arterial hypertension (PAH) are derived from clinical trials in adult populations and from clinical practice, but…”
Get full text
Journal Article -
10
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study
Published in The American heart journal (01-02-2014)“…Background Epoprostenol sodium with arginine-mannitol excipients (epoprostenol AM; Veletri [Actelion Pharmaceuticals Ltd, Allschwil, Switzerland]) and…”
Get full text
Journal Article -
11
Echocardiographic Changes and Long-Term Clinical Outcomes in Pediatric Patients With Pulmonary Arterial Hypertension Treated With Bosentan for 72 Weeks: A Post-hoc Analysis From the FUTURE 3 Study
Published in Frontiers in pediatrics (16-06-2021)“…FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion (FUTURE) 3 was a 24-week open-label, prospective, and randomized phase 3 study that assessed the…”
Get full text
Journal Article -
12
Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease
Published in Journal of Alzheimer's disease (01-01-2012)“…Biomarkers have gained an increased importance in the past years in helping physicians to diagnose Alzheimer's disease (AD). This study was designed to…”
Get more information
Journal Article -
13
A predictive microarray-based biomarker for early detection of Alzheimer's disease intended for clinical diagnostic application
Published in Biomarkers (01-05-2013)“…Abstract Objective: Microarray-based signatures for clinical application are often plagued by processing variability or batch effects that compromise the…”
Get full text
Journal Article -
14
Performance of DETECT PAH algorithm according to the hemodynamic definition of pulmonary arterial hypertension (PAH) in the 2022 ESC/ERS guidelines: Early detection of pulmonary arterial hypertension in systemic sclerosis patients
Published in Arthritis & rheumatology (Hoboken, N.J.) (27-12-2023)“…The evidence-based DETECT pulmonary arterial hypertension (PAH) algorithm is frequently used in systemic sclerosis (SSc) patients to help clinicians screen for…”
Get full text
Journal Article -
15
Peripheral Nerve Stimulation of Brachial Plexus Nerve Roots and Supra-Scapular Nerve for Chronic Refractory Neuropathic Pain of the Upper Limb
Published in Neuromodulation (Malden, Mass.) (01-10-2017)“…We report the outcome of a consecutive series of 26 patients suffering from chronic medically-refractory neuropathic pain of the upper limb (including 16…”
Get more information
Journal Article -
16
Effect of Bosentan and Sildenafil Combination Therapy on Morbidity and Mortality in Pulmonary Arterial Hypertension (PAH): Results From the COMPASS-2 Study
Published in Chest (01-10-2014)Get full text
Journal Article -
17
Évolution de la destruction des culots globulaires : établissement MCO et 28 ans de recul
Published in Transfusion clinique et biologique : journal de la Société française de transfusion sanguine (01-11-2018)“…La clinique Saint-Léonard est un établissement médicochirurgical, centré sur la prise en charge médicochirurgical de l’appareil locomoteur. Les actes…”
Get full text
Journal Article -
18
Évolution de la transfusion homologue depuis 3 ans
Published in Transfusion clinique et biologique : journal de la Société française de transfusion sanguine (01-11-2018)“…La clinique Saint-Léonard est un établissement médicochirurgical, centré sur la prise en charge médicochirurgical de l’appareil locomoteur. Les actes…”
Get full text
Journal Article -
19
Autotransfusion périopératoire : évolution sur 18 ans dans un établissement MCO
Published in Transfusion clinique et biologique : journal de la Société française de transfusion sanguine (01-11-2018)“…La clinique Saint-Léonard est un établissement médicochirurgical, centré sur la prise en charge médicochirurgical de l’appareil locomoteur. Les actes…”
Get full text
Journal Article -
20
Suivi sur 17 ans des FEIR : évolution dans un établissement MCO
Published in Transfusion clinique et biologique : journal de la Société française de transfusion sanguine (01-11-2018)“…La clinique Saint-Léonard est un établissement médicochirurgical, centré sur la prise en charge médicochirurgical de l’appareil locomoteur. Les actes…”
Get full text
Journal Article